Integrity Compromised: De Lima question AFP Chief’s loyalty over letter to Chinese Amb

Integrity Compromised: De Lima question AFP Chief’s loyalty over letter to Chinese Amb




Detained opposition senator Leila De Lima has called out the actions of Chief of Staff of the Armed Forces of the Philippines (AFP) Felimon Santos, Jr. an has branded it as “wrong on so many levels” when he asked Chinese ambassador to the Philippines Huang Xilian to buy a drug for novel coronavirus disease 2019 or COVID-19.

In a statement, De Lima said Santos’ request was “wrong [on] so many levels” considering his position in government. He said the AFP chief could be held liable for violation of the Anti-Graft and Corrupt Practices Law and the Medical Act, which prohibits dispensation of medicine by a non-licensed individual.


The opposition senator said Santos’ request to Huang cast doubts on the AFP chief’s integrity.

Detained opposition senator Leila De Lima
(photo credit to owner)


“For him to owe a debt of gratitude to any foreign entity is a conflict of interest at best and treason at worst. Kailangan natin ng armed forces chief na hindi nabibili ng sinuman, lalo na ng mga dayuhan,” she said.

AFPCS Santos had written Ambassador Huang to ask for help in buying Carrimycin, which he claimed helped him personally to recover from COVID-19.

Santos said he withdrew the letter after finding out the supposed medicine was not yet registered with the Food and Drug Administration (FDA).






What can you say about this?

Share us your thoughts by simply leaving on the comment section below. For more news updates, feel free to visit our site often.


Stay updated with today's relevant news and trends by hitting the LIKE button.


Thanks for dropping by and reading this post.


Report from Politiko


Disclaimer: Contributed articles does not reflect the view of THE PH CHRONICLES. This website cannot guarantee the legitimacy of some of the information contributed to us. You may do additional research if you find some information doubtfulNo part of this article maybe reproduced without permission from this website.

Post a comment

0 Comments